Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 May 7;11(5):837.
doi: 10.3390/diagnostics11050837.

Lung Nodules in Melanoma Patients: Morphologic Criteria to Differentiate Non-Metastatic and Metastatic Lesions

Affiliations

Lung Nodules in Melanoma Patients: Morphologic Criteria to Differentiate Non-Metastatic and Metastatic Lesions

Simone Alexandra Stadelmann et al. Diagnostics (Basel). .

Abstract

Lung nodules are frequent findings in chest computed tomography (CT) in patients with metastatic melanoma. In this study, we assessed the frequency and compared morphologic differences of metastases and benign nodules. We retrospectively evaluated 85 patients with melanoma (AJCC stage III or IV). Inclusion criteria were ≤20 lung nodules and follow-up using CT ≥183 days after baseline. Lung nodules were evaluated for size and morphology. Nodules with significant growth, nodule regression in line with RECIST assessment or histologic confirmation were judged to be metastases. A total of 438 lung nodules were evaluated, of which 68% were metastases. At least one metastasis was found in 78% of patients. A 10 mm diameter cut-off (used for RECIST) showed a specificity of 95% and a sensitivity of 20% for diagnosing metastases. Central location (n = 122) was more common in metastatic nodules (p = 0.009). Subsolid morphology (n = 53) was more frequent (p < 0.001), and calcifications (n = 13) were solely found in non-metastatic lung nodules (p < 0.001). Our data show that lung nodules are prevalent in about two-thirds of melanoma patients (AJCC stage III/IV) and the majority are metastases. Even though we found a few morphologic indicators for metastatic or non-metastatic lung nodules, morphology has limited value to predict the presence of lung metastases.

Keywords: malignant melanoma; multi-detector computed tomography; pulmonary nodules.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Characteristics of lung nodules. (a): solid nodule; (b): part-solid nodule; (c): ill-defined margin; (d): lobulated margin; (e): spiculated margin; (f): pleural retraction; (g): feeding vessel; (h): air bronchogram.
Figure 2
Figure 2
Flow chart illustrating derivation of our final study cohort. American Joint Committee on Cancer (AJCC). Computed Tomography (CT).
Figure 3
Figure 3
Receiver Operating Characteristic (ROC) curve illustrating the Area Under the Curve (AUC) for average nodule diameter (blue), maximum long axis diameter (red) and nodule volume (green) to predict metastases. There were no significant differences between ROC curves calculated with DeLong’s test (p = 0.059–0.325).

Similar articles

Cited by

References

    1. Guy G.P., Jr., Thomas C.C., Thompson T., Watson M., Massetti G.M., Richardson L.C., Centers for Disease Control and Prevention (CDC) Vital signs: Melanoma incidence and mortality trends and projections—United States, 1982–2030. MMWR Morb. Mortal. Wkly. Rep. 2015;64:591–596. - PMC - PubMed
    1. Knackstedt T., Knackstedt R.W., Couto R., Gastman B. Malignant Melanoma: Diagnostic and Management Update. Plast. Reconstr. Surg. 2018;142:202e–216e. doi: 10.1097/PRS.0000000000004571. - DOI - PubMed
    1. Belhocine T.Z., Scott A.M., Even-Sapir E., Urbain J.L., Essner R. Role of nuclear medicine in the management of cutaneous malignant melanoma. J. Nucl. Med. 2006;47:957–967. - PubMed
    1. Neuman H.B., Patel A., Hanlon C., Wolchok J.D., Houghton A.N., Coit D.G. Stage-IV melanoma and pulmonary metastases: Factors predictive of survival. Ann. Surg. Oncol. 2007;14:2847–2853. doi: 10.1245/s10434-007-9448-y. - DOI - PubMed
    1. Sandru A., Voinea S., Panaitescu E., Blidaru A. Survival rates of patients with metastatic malignant melanoma. J. Med. Life. 2014;7:572–576. - PMC - PubMed

LinkOut - more resources